IV rank extremes

Which liquid tickers had the highest and lowest 52-week implied-volatility rank on Oct 15, 2026?

The 25 highest observations appear first, followed by the 25 lowest. IV rank locates current average implied volatility between its trailing 52-week low and high; it is not an option-pricing recommendation. Data through Oct 15, 2026 close. Descriptive only, not a recommendation.

At a glance

50 tickers qualified. First five: TLT (100.0), SPCX (100.0), WBD (100.0), GME (100.0), CIFR (100.0).

IV rank extremes as of Oct 15, 2026 close
#	Ticker	Close	Open interest	IV rank
1	TLT	79.97	14,862,324	100.0
2	SPCX	148.62	4,768,181	100.0
3	WBD	30.98	2,502,443	100.0
4	GME	28.02	2,025,839	100.0
5	CIFR	10.04	1,980,004	100.0
6	F	12.31	1,805,520	100.0
7	USO	157.31	1,755,463	100.0
8	ASTS	44.46	1,317,748	100.0
9	C	123.22	1,209,763	100.0
10	POET	6.01	1,168,153	100.0
11	SKHY	146.11	1,107,841	100.0
12	AG	16.09	1,094,461	100.0
13	SLS	11.34	1,052,481	100.0
14	KEEL	2.57	1,037,996	100.0
15	SNDK	1,394.83	1,011,678	100.0
16	CVNA	60.62	991,852	100.0
17	CMG	30.57	942,686	100.0
18	ARM	244.79	924,684	100.0
19	CSCO	109.85	907,095	100.0
20	JD	27.39	893,630	100.0
21	APLD	20.39	887,717	100.0
22	XSP	774.41	871,770	100.0
23	RUT	2,767.28	860,301	100.0
24	OWL	8.97	850,069	100.0
25	HIMS	29.38	844,774	100.0
26	VIX	16.46	15,222,281	5.4
27	AMC	3.02	1,053,475	8.7
28	MSTR	151.29	2,661,257	9.8
29	HTZ	1.83	1,185,622	11.2
30	STLA	4.35	434,081	14.6
31	AGNC	8.82	810,920	14.9
32	LAC	2.24	344,901	15.8
33	RXT	3.18	127,653	15.8
34	CAG	14.18	188,926	16.3
35	SOFI	15.09	4,243,698	16.4
36	RIG	5.51	1,180,047	18.3
37	SMR	6.15	531,611	18.3
38	NIO	3.50	2,499,785	19.0
39	TQQQ	73.82	1,673,188	19.0
40	SMCI	35.09	2,229,781	19.4
41	BEKE	17.83	262,382	19.4
42	KVUE	18.67	134,118	20.2
43	DRAM	49.33	2,586,092	20.4
44	BB	8.70	590,697	21.7
45	AI	12.16	333,001	22.5
46	SERV	3.49	224,679	23.0
47	PTON	5.33	897,160	23.4
48	UAMY	2.78	207,373	23.4
49	NFLX	72.61	5,237,788	24.4
50	LCID	3.50	912,496	24.4

Screens describe what the data shows after the close. They are not trade recommendations; see the disclaimer and the methodology.